Atlas Trials

Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects

Clinical trial NCT04334460 · COMPLETED

Trial details

NCT number
NCT04334460
Sponsor
Blade Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sars-CoV-2Covid19
Start date
2020-05-04
Primary completion
2020-11-11
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.